What is the proper dosage for Dynadol (paracetamol) tablets?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dynadol (Paracetamol) Dosing Guidelines

For adults, the standard dose of paracetamol (acetaminophen) is 650-1000 mg every 4-6 hours, with a maximum daily dose of 4000 mg (4 grams), though some manufacturers have voluntarily reduced this to 3000-3250 mg daily. 1, 2

Standard Adult Dosing

  • Adults and children ≥12 years should take 650 mg (20.3 mL if liquid) every 4-6 hours, not exceeding 6 doses in 24 hours 1

  • The optimal single dose for adults is 1000 mg (1 gram), with maximum daily dosage of 4000 mg, consistent with analgesic activity duration of approximately 6 hours 3

  • At therapeutic concentrations, paracetamol pharmacokinetics are linear and dose-independent, meaning the drug behaves predictably within the recommended range 3

Pediatric Dosing

  • Children 6 to <12 years: 325 mg (10.15 mL) every 4 hours, maximum 5 doses per 24 hours 1

  • Children 4 to <6 years: 240 mg (7.5 mL) every 4 hours, maximum 5 doses per 24 hours 1

  • Children 2 to <4 years: 160 mg (5 mL) every 4 hours, maximum 5 doses per 24 hours 1

  • An oral dose of 15 mg/kg every 4 hours, up to a total of 60 mg/kg/day, is usually sufficient for analgesic or antipyretic effect in children 3

  • The pediatric dose varies globally between 10-15 mg/kg; in the UK, 10 mg/kg is given every 4 hours up to four doses daily, while in Australia, 15 mg/kg is administered 4-hourly up to 60 mg/kg/day 4

Maximum Daily Dose Controversy

  • There is current confusion regarding maximum daily dosing, as McNeil voluntarily reduced the maximum daily dose of 500 mg tablets to 3000 mg/day and pledged to change 325 mg tablet labeling to 3250 mg/day, while generic manufacturers maintain the FDA monograph dose of 3900-4000 mg 2

  • The FDA-established maximum daily therapeutic dose remains 3900-4000 mg (established in 1977 and 1988), though the FDA has suggested (but not mandated) reduction to 3000-3250 mg 2

Special Populations

  • No routine dose reduction is required for older adults; dosing should be individualized only for those with decompensated cirrhosis, advanced kidney failure, or known paracetamol-sensitive asthma 5

  • Paracetamol is the non-opioid analgesic of choice in elderly persons or patients with chronic renal insufficiency, and dosage reduction is usually unnecessary even though clearance is reduced 3

  • The drug is contraindicated in patients with hepatic insufficiency, though bioavailability is not impaired in chronic benign liver disease 3

  • Paracetamol can be used during pregnancy and lactation 3

Critical Safety Considerations

  • Single ingestions exceeding ten times the recommended dose (>40 grams for adults) are potentially hepatotoxic 4

  • Chronic exposures greater than 140 mg/kg/day for several days carry risk of serious hepatotoxicity 4

  • Hepatotoxicity from therapeutic doses is rare among adults using paracetamol as directed, including those with cirrhotic liver disease 5

  • The maximum daily dose of 4000-6000 mg should never be exceeded, as stated in cancer pain management guidelines 6

Formulation Considerations

  • Effervescent tablets provide more rapid drug absorption and onset of action compared to conventional tablets 3

  • Rectal administration differs from oral route due to slow and irregular absorption 3

  • There is no direct correlation between serum concentrations and analgesic or antipyretic effect 3

Common Pitfalls to Avoid

  • Failing to account for paracetamol content in combination products (e.g., with opioids or other analgesics) can lead to inadvertent overdosing, as over 200 million paracetamol-containing prescriptions are dispensed annually 2

  • The very low plasma protein binding and hepatic metabolism primarily through glucuronide or sulfate conjugation result in low risk of drug interactions, particularly with anticoagulants 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.